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ABSTRACT

Non-naturally occurring DNA promoters, include MSGTPFlt, PFlt-UAS-2X and FSgt-PFlt. The MSGT-PFlt was
developed and has expression shown to be equivalent to that
of CaMV35S promoter. DNA promoters PFlt-UAS-2X and
FSgt-PFlt were developed and tested in transient and transgenic system and found to be stronger than the CaMV35S
promoter.
4 Claims, 23 Drawing Sheets

~

00

•

~

FIGURE!

~

Sequence ID No 1: DNA Sequence ofpromoter clone PFit-UAS-lX, 376-hp, (coordinat.e in respect oft.ranscription start site,
TSS, -352 to +24)
l,GTTTTTl',CT
GATTTCTCTG
ACCTAAAGCA
CTCAGAl,CCT
GCCTATAAJI.T

TCGGACAGTC
AAGATCATGT
ATAATGGAGC
TTI-\.CTTTTTJ\
l\.AGTTTTAGT

Al,Ai\ATGAGT
TTGCCAGCTA
CATGACGTAA
TATTTGGCGT
TTGTATTG.l'.. T

TTAl-,CTTCTC
TGCGAACAAT
GGGCTTACGC
GTATTTTTAA
CGAC]I.CGATC

l\GCCGl',GGTA
CATCGGGAGA
CCATACGAAA
ATTTCCACGG
GAGl-\.AGI-\.CAC

AAACAAGl-\AA
TCTTGAGCCA
TAATTAAAGG
CAATG.A_CGAT
GGCCAT

Tl\TGCTTACG
ATCAl-\.AGAGG
CTGATGTGAC
GTGACCTGTG

TCTACAGAGG
AGTGATGTAG
CTGTCGGTCT
CATCCGCTTT
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Sequence ID No 2: DNA Sequence of promoter clone PFit-UAS-2X, 686-bp; coordinate in respect of transcription start site
(TSS) -662 to +24
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AGTTTTTACT TCGGACl\_GTC AAAAATGAGT
GA'l"l"l'CTC'I'G AAGATCA'l'G'l' 'l'GCCAGCTA'I'
CC'I'AAAGCa~ T&~TGGAGCC ATGACGTl\AG
TCAGAACCTT TACTTTTTAT ATTTGGCGTG
'l'CGGACAG'I'C AAAAA'l'GAG'l' 'l"l'AACTTC'I'C
AAGATCATGT TTGCCAGCAA TGCGAACAAT
ATAATGGAGC CATGACGTAA GGGCTTACGC
'I''I'AC'l''l''l''l"l'A 'l'A'l''l'TGGCG'I' G'I'A'l'T'l"l'TAA
l\_~GTTTTAGT TTGTATTGAT CGACACGATC

TTAI>.CTTCTC
GCGAACAA'l'C
GGCTTACGCC
TATTTTTAAA
AGCCGAGG'l'A
CATCGGGAGA
CCATACGAAA
A'l'T'l'CCACGG
GAGA]I_GACAC

l-\.GCCGAGGTA AAACI>.AGAN\ TATGCTT.Z-\.CG
A'l'CGGGAGA'I' CTTGAGCCAA 'l'CAAAGAGGA
CATACGAa~T AATTAAAGGC TGATGTGACC
TTTCCACGGC AATGACGAGG TGACCCAACG
AAACAAGllli1\ TATGC'l"l'ACC TC'l'ACAGAGG
TCCTGAGCCA ATCAAAGAGG AGTGATGTAG
TAATTAAAGG CTGATGTGAC CTGTCGGTCT
CAA'l'GACGA'l' G'l'GGCCTG'I'G Cl\TCCGC'l"l'T
GGCCAT

TCTACI>.GAGG
GTGA'I'G'l'AGA
TGTCGGTCTC
AGTTTTTACT
GATTTC'l'C'l'C
ACCTAAAGCA
CTCAGAACCT
CCC'l'ATAAAT
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Sequence ID No 3: DNA Sequence of promoter clone FSgt-PFlt, 593-bp, coordinate in respect of transcription start site (TSS):
-569 to +24
TTACAGTAAG li..ACTGATAAC AAAAATTTTA
GTCCGTTGGC l\.AA]I_TTGGTT Cl\_GCAGGT.~'I'
CCTCACGAGA GATTTTAATC CTTAAAAACG
l\.ATG.~GTTTA ACTTCTCAGC CGAGGTa~
CCAGCAATGC GAACAATCAT CGGGAGATCC
GACG'l'AAGGG CTTACGCCCA 'l'ACGAAATAA
TTGGCGTGTA TTTTTi-\.AATT TCCACGGCAA
TATTGATCGA CACGATCGAG AAGii.CACCGC

CTTATTTCCT
CAAT'I''I'GATG
TAAGCCCTGll.
Cl\AGAAATAT
TGAGCCAATC
T"I'AAAGGC'l'G
TGACGATGTG
CAT

TAGAATTAAT CTTAAAGGTG
TCGl\.AC.~TC'I' TGAAGG'I'G'I'A
CGTATGATTT CCCAACGAGT
GCTT]I.CGTCT ACAGAGGGli.T
AAAGAGGAGT GATGTAGACC
A'l'G'l'GACCTG TCGGTCTC'l'C
GCCTGTGCAT CCGCTTTGCC

ATAGTAAACA
AAAAACGTTT
TTTTACTTCG
TTCTCTGAAG
TAAAGCAATA
AGAACCT'l'TA
TATAAATAAG

AGGACGATTA
TAGCAGl\_TTG
GACAGTC&".A
ATCl\_TGTTTG
ATGGAGCCAT
C'I'TTT"I'Nl'AT
TTTTAGTTTG
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Sequence ID No 4: DNA Sequence of promoter clone MSgt-PFlt

CGGTAAAACA
TGTAAATCTT
TGGCAAATGT
ATTATCTCAC
CCGAGGTAAA
CGAACAATCA
TGACGTAAGG
ACTTTTTATA
CTATAAATAA

GGTGATTACT
TTAAAAGGAT
GGTTTTCACA
CAGAGAATTC
ACAAGAAATA
TCGGGAGATC
GCTTACGCCC
TTTGGCGTGT
GTTTTAGTTT

AAATTTAGTA
TTATGAATAA
TTACACCTTT
CCCCAACGAG
TGCTTACGTC
CTGAGCCAAT
ATACGAAATA
ATTTTTAAAT
GTATTGATCG

TTTATCTAAC
AAAGATTACT
AAGGTGGACC
TTTTTACTTC
TACAGAGGGA
CAAAGAGGAG
ATTAAAGGCT
TTCCACGGCA
ACACGATCGA

~

CCCTGTTTGT
GGTGACAGTA
ACCTAAAAGG
GGACAGTCAA
TTTCTCTGAA
TGATGTAGAC
GATGTGACCT
ATGACGATGT
GAAGACACGG

TTTACAGTCA
AACAGGGAAG
AGAACAAAAT
AAATGAGTTT
GATCATGTTT
CTAAAGCAAT
GTCGGTCTCT
GGCCTGTGCA
CCAT

GGACAGATAA
GCTAATAAGA
GTGCTGGCTG
AACTTCTCAG
GCCAGCAATG
AATGGAGCCA
CAGAACCTTT
TCCGCTTTGC
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Sequence ID No 5: DNA Sequence of PFlt promoter fragment

AGTTTTTACT
TCTACAGAGG
ATCAAAGAGG
TAATTAAAGG
ATTTCCACGG
CGACACGATC

TCGGACAGTC
GATTTCTCTG
AGTGATGTAG
CTGATGTGAC
CAATGACGAT
GAG&~GACAC

AAAAATGAGT
AAGATCATGT
ACCTAAAGCA
CTGTCGGTCT
GTGACCTGTG
GGCCAT

TTAACTTCTC
TTGCCAGCTA
ATAATGGAGC
CTCAGAACCT
CATCCGCTTT

AGCCGAGGTA
TGCGAACAAT
CATGACGTAA
TTACTTTTTA
GCCTATAAAT

AAACAAGAAA
CATCGGGAGA
GGGCTTACGC
TATTTGGCGT
AAGTTTTAGT

TATGCTTACG
TCTTGAGCCA
CCATACGAAA
GTATTTTTAA
TTGTATTGAT
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GUS Activity in tobacco protoplast
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UNIQUE NUCLEIC ACID PROMOTER
FORMED FROM TWO OR MORE
PROMOTER SEQUENCES

bp between two promoters often lead to gene silencing in
transgenic plants (Flavell, 1994).
SUMMARY OF THE INVENTION

CROSS-REFERENCE TO RELATED
APPLICATION
This application claims the benefit of U.S. Provisional
Patent Application No. 61/819,017, filed May 3, 2013, herein
incorporated by reference.

10

FIELD OF THE INVENTION
The present application relates to DNA promoters for gene
expression and in particular unique promoters formed from
DNA fragments. Advantageously, the present promoter DNA
has enhanced activity in terms of gene expression. The
present invention also relates to methods for producing
unique promoters.

15

20

BACKGROUND OF THE INVENTION
The key genetic regulator, promoter, usually determines
the ultimate fate of gene transcription. The structure of
eukaryotic promoter is modular comprising a distal upstream
activating sequence (UAS) and a proximal core promoter
containing TATA element. Both distal and proximal regions
are embedded with a number of cis elements which acts as the
binding sites of different transcription factors and transcription binding proteins (TBPs) while RNA polymerase binds to
the proximity ofTATA box. The combinatorial/spatial interactions between cis and trans factor along with the cross talk
between the proximal and distal part of promoter usually
determines the functional characteristics of the promoter and
regulate the gene transcription (Goodrich and Tjian, 2010;
Lee and Young, 2000). Based upon these factors, redesigning
of promoter structure by genetic manipulations could be possible to develop a better promoter with altered cis-profiles/
cis-arrangements. Such 'tailor-promoter' usually holds better
promise for developing plant of interest in comparison to the
native promoter. Exchanging/swapping/shuffling the proximal and distal domains among different native (plant/animal)
promoter sequences, one can develop unique recombinant
promoter-module that manifest functional properties combining the features of both donating and receiving promoters
(Venter and Botha, 2010; Bhullar eta!., 2003; Venter, 2007).
Several engineered/modified promoters were developed in
recent past (Comai eta!., 1990, Ni eta!., 1995; Lee eta!.,
2007; Rushton eta!., 2002; Venter, 2007). The present inventors have developed several useful plant promoters using both
full-length transcript (Fit-) and sub-genomic transcript (Sgt-)
promoters from different members of pararetrovirus (Kumar
eta!., 2011; Ranjan eta!., 2012; Patro eta!., 2012, Kumar et
a!., 2012). Unfortunately, the availability of such engineered
promoters is not sufficient to meet their current demand in
plant molecular biology and there is a constant shortage of
such promoter in plant molecular biology.
Again, in eukaryotes a single gene requires a promoter for
its expression. Therefore, during gene stacking or gene pyramiding, one needs to use multiple numbers of heterologous
promoters for expression multiple numbers of genes. There is
possibility of promoter sequence homology based genetic
rearrangement/recombination in case of repeated use of same
promoter for expressing multiple number of gene in plant
cell. In such cases, use of different heterologous promoters
could be advantageous over multiple use of same promoter as
it was documented that homologous sequences, more than 90
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The present invention relates to unique, non-naturally (i.e.
not found in nature) occurring promoters produced from fragments or full sequences of promoters from genomes ofPF!tUAS-2X and FSgt-PF!t from Peanut Chlortic Streak Virus
(PC1SV) and Figwort Mosaic Virus (FMV) as well as MSgtPF!t from genomes of the Peanut Chlortic Streak Virus
(PC1SV) and Mirabilis Mosaic Virus (MMV). In addition,
promoters in accordance with the disclosure include combinations of the aforementioned fragments. The present invention also relates to method for producing aforementioned
non-naturally occurring promoters.
In accordance with this disclosure, an engineered genetic
promoter DNA fragments obtained from Peanut Chlortic
Streak Virus (PC1SV) and Figwort Mosaic Virus (FMV)
includes promoters (i) PF!t-UAS-2X: developed by inserting
an additional copy of a sub genomic transcript promoter
fragment (-352 to -49) of Peanut Chlortic Streak Virus
(PC1SV-Sgt) to the 5' end of TATA containing PC1SV-Flt
promoter fragment between coordinates -352 to +24 and (ii)
FSgt-PF!t: constructed by ligating a sub genomic transcript
promoter fragment (-270 to -60) of Figwort Mosaic Virus
(FMV-Sgt) to the 5' end of a PC1SV-Flt promoter fragment
between coordinates -352 to +24.
This disclosure includes a technique for obtaining genetic
promoters DNA fragments from Figwort Mosaic Virus
(FMV) comprising isolating FMV Sgt promoters plus UAS
domain of full length transcript of Peanut Chlortic Streak
Virus (PC1SV). Further, this disclosure includes methods of
assaying promoter activities subjecting to the isolation PF!tUAS-2X and FSgt-PF!t promoters of Peanut Chlortic Streak
Virus (PC1SV) and Figwort Mosaic Virus (FMV) Sgt promoters to the step of molecular cloning and determining the
activities of the promoters both in transient and transgenic
assay.
Further, the disclosure provides a technique for enhancing
the activity of genetic promoter fragment.
The engineered promoters include PF!t-UAS-2X and
FSgt-PF!t withhigherefficacy of successful gene transformation in plant. The 305 bp long UAS domain of full-length
transcript promoter fragment (-353 to -49) of Peanut Chlortic Streak Virus (PC1SV-Flt) was inserted at the 5' end of
TATA containing PC1SV-Flt promoter fragment ( -352 to
+24) to develop 686 bp long full length transcript promoter
fragment of Peanut Chlortic Streak Virus with double
enhancer domain PF!t-UAS-2X. Likewise, a 211 bp long
UAS domain ofFigwort Mosaic Virus sub genomic transcript
promoter fragment (-270 to -60) was ligated to the 5' end of
a PC1SV-Flt promoter fragment between coordinates -352 to
+24 to develop a recombinant promoter of 593 bp long FSgtPF!t.
The inventors have evaluated the transient activities of
these two newly derived promoter fragments; PF!t-UAS-2X
and FSgt-PF!t in tobacco protoplast system along with their
transgenic activities were tested in transgenic tobacco plants.
The inventors have compared their transient and transgenic
activities with that of the CaMV35S promoter and also
observed positive correlation among the GUS activities of
transgenic tobacco plant expressing PF!t-UAS-2X and FSgtPF!t promoter separately with the accumulation level of corresponding uidA transcript in transgenic plant. Histochemical staining of different parts of transgenic plant expressing
PF!t-UAS-2X and FSgt-PF!t promoter construct individually
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confirms that they are semi-constitutive in nature. Taken all
together, the newly derived pararetrovirus based recombinant
sub-genomic transcript promoters; PFlt-UAS-2X and FSgtPFlt are additional molecular tools for transgenic plant development with much higher efficacy than the CaMV35S promater. Thus they could become potential candidate-promoter
for multi-gene based molecular pharming and plant metabolic engineering.
In addition, the present invention relates to an engineered
genetic promoter DNA fragment obtained from Peanut Chlortic Streak Virus (PClSV) and Mirabilis Mosaic Virus
(MMV) wherein the promoter, MSgt-PFlt, constructed by
ligating a sub genomic transcript promoter fragment ( -356 to
-125) ofMirabilis Mosaic Virus (MMV-Sgt) to the 5' end of
a PClSV-Flt promoter fragment between coordinates -352 to
+24 (PFlt-UAS-lX).
The present invention also relates to a technique foro btaining genetic promoter DNA fragment from Mirabilis Mosaic
Virus (MMV) comprising isolating MMV Sgt promoter plus
UAS domain of full-length transcript of Peanut Chlortic
Streak Virus (PC! SV). This invention also relates to methods
of assaying promoter activities subjecting isolation of the
MSgt-PFlt promoter from Peanut Chlortic Streak Virus
(PC! SV) and Mirabilis Mosaic Virus (MMV) Sgt promoters
to the steps of molecular cloning and determining the activities of the promoter both in transient and transgenic assay.
Further, the present invention relates to expression of
immunological gene and immunological gene of interest in
plant protoplast using engineered promoters, e.g. PFlt-UAS2X and FSgt-PFlt and MSgt-PFlt.
As will be clear from the following discussion, the present
promoters allow for enhanced gene expression in plants.
The engineered promoter namely, MSgt-PFlt with complete heterogenous sequences and possess almost equal transcriptional activity to that of the most widely used promoter,
the CaMV35S. A 232 bp long UAS domain of Mirabilis
Mosaic Virus sub-genomic transcript promoter fragment
(-356 to -125) was ligated to the 5' end of a PClSV-Flt
promoter fragment between coordinates -352 to +24 to
develop the recombinant promoter MSgt-PFlt (614 bp). The
transient activities of this newly derived promoter fragment
were evaluated; MSgt-PFlt in tobacco protoplast system,
along with transgenic activities tobacco plants. Furthermore,
the inventors compared its transient and transgenic activities
with that of the CaMV35S promoter. In this regard, the inventors have observed positive correlation among the average
GUS activities obtained from transgenic tobacco plant
expressing MSgt-PFlt with the accumulation level of corresponding uidA transcripts in transgenic plant. Histochemical
staining of different parts of transgenic plant expressing the
MSgt-PFlt promoter construct confirms that it is a semiconstitutive promoter. Taken all together, the newly derived
pararetrovirus based recombinant sub-genomic transcript
promoter; MSgt-PFlt can be additional molecular tool for
transgenic plant development with equivalent efficacy with
that of the CaMV35S promoter. The recombinant promoter,
MSgt-PFlt, reported in the present invention could be used as
an alternative of the CaMV35S in plant biology; thus, it could
become a potential candidate-promoter for multi-gene based
molecular pharming and plant metabolic engineering.

single enhancer domain of sub-genomic transcript ofFigwort
Mosaic Virus ligated to the full length transcript of Peanut
Chlortic Streak Virus.
FIG. 2 includes schematic diagrams of gene expression
cassettes for Pft-UAS-lX (A), PFit-UAS-2X (B) and FSgtPFlt (C) promoters respectively GUS-13 glucuronidase;
Kanr- Kanamycin resistant gene.
FIG. 3 shows transient activities ofCaMV3 5S, PFlt-UASlX, PFlt-UAS-2X and FSgt-PFlt promoters in tobacco protoplast system coupled to GUS reporter gene.
FIG. 4 shows green florescence obtained from ImaGene
Green treated transformed protoplast expressing CaMV 35S,
PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFit (coupled to GUS
reporter gene). Panel!, Panel2 and Panel3 represent bright
field images, green fluorescence images and superimposed
images respectively obtained from transformed protoplast
expressing above promoter constructs.
FIG. 5 shows the transgenic promoter activities of
CaMV35S, PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt promoter coupled to GUS reporter gene. The data presented are
means of five independent experiments with respective standard deviation. For each construct, eight to ten independent
transgenic lines developed. Untransformed control (Wild),
tissue extract from wild-type N. tabacum cv. SamsunNN.
FIG. 6 shows real-time PCR based quantitative estimation
of GUS transcripts accumulation in transgenic plants
expressing GUS under the control of CaMV35S, PFlt-UASlX, PFit-UAS-2X and FSgt-PFlt promoters. The data presented as an average fold differences of GUS transcript with
corresponding standard deviation of three independent
experiments. Each bar represents 4.2 fold difference ofuidA
level in transgenic plants expressing above promoter constructs independently considering the accumulation of
mRNA level by CaMV35S promoter a value of 1.
FIG. 7 shows expression of mammalian Interleukin 2 (IL2) protein in tobacco protoplast under control of PFlt-UASlX, PFlt-UAS-2X and FSgt-PFlt promoter.
FIG. 8 shows images ofX-Gluc staining (Histochemical
analysis) leaf petiole cross section of 21 days old transgenic
plants expressing GUS under the control ofCaMV 35S, PFltUAS-2X and FSgt-PFlt promoters (details of assay discussed
under Example 3).
FIG. 9 shows the DNA sequences for SEQ ID NOS: 4 and
5, in which SEQ ID NO: 4 is the DNA sequence of promoter
clone MSgt-PFlt, in accordance with the present invention
(i.e. the UAS domain of full length transcript promoter from
Peanut Chlortic Streak Virus; PFlt promoter fragment and the
newly derived promoter MSgt-PFlt) and SEQ ID NO: 5 is the
DNA sequence of a PFlt promoter fragment, in accordance
with the present invention.
FIG. 10 shows schematic diagrams of gene expression
cassettes carrying PFlt promoter fragment (A) and MSgt-PFit
(B) promoters respectively coupled to GUS reporter gene;
GUS-~ glucuronidase; Kanr- Kanamycin resistant gene.
FIG. 11 shows transient activities ofCaMV35S, PFlt promoter fragment and MSgt-PFlt promoters in tobacco protoplast system coupled to GUS reporter gene.
FIG. 12 shows green florescence obtained from ImaGene
Green treated transformed protoplast expressing corresponding promoter as mentioned above. Panel!, Panel 2 and Panel
3 represent bright field images, green fluorescence images
and superimposed images respectively obtained from transformed protoplast expressing above promoter constructs.
FIG. 13 shows the transgenic promoter activities of
CaMV35S, PFlt and MSgt-PFlt promoter coupled to GUS
reporter gene. The data represented are means of five independent experiments with respective standard deviation. For
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FIG.1 shows the DNA sequences, SEQ ID NOS: 1-3, of the
promoter PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt with
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each construct, eight to ten independent transgenic lines
ing prpmoter sequences from Peanut Chlortic Streak Virus
developed. Untransformed control (Wild), tissue extract from
and Figwort mosaic virus. This invention also relates to a
wild-type Nicotiana tabacum cv. SamsunNN.
method of using the promoters in plant and protoplast system
FIG. 14 shows real-time PCR based quantitative estimafor expression of any trans gene. Features include:
tion of GUS transcript accumulation in transgenic plants 5
Molecular cloning of PF!t-UAS-lX (PClSV genomic
expressing GUS under the control of CaMV35S, PF!t procoordinate 5725 to 6100, PClSV-Flt promoter coordimoter fragment and MSgt-PFit promoters. The data prenates
-352 to +24 from TSS) from Peanut Chlortic
sented as an average fold differences of GUS transcript with
Streak Virus full-length transcript.
corresponding standard deviation of three independent
Molecular cloning of upstream activation sequence
experiments. Each bar represents fold difference of uidA
10
level in transgenic plants expressing above promoter con(PClSV genomic coordinates 5725 to 6100, PClSV
structs independently considering the accumulation of GUSpromoter coordinates -352 to -49) from Peanut Chlortic
mRNA level by CaMV3 5S promoter a value of 1.
Streak Virus full-length transcript (PF!t-UAS-1 X) proFIG. 15 shows expression of mammalian Interleuk:in-2
moter.
(IL-2) protein in tobacco protoplast under control ofCaMV
Molecular cloning of domain containing upstream activat15
35S, PF!t and MSgt-PF!t promoter.
ing sequence, from Figwort mosaic virus sub-genomic
FIG. 16 shows images ofX-Gluc staining (Histochemical
transcript (FMV-Sgt) promoter. (UAS from FMV
analysis) leaf petiole cross section of 21 days old transgenic
genomic coordinates 5163 to 5363; FMV-Sgt promoter
plants expressing GUS under the control of CaMV35S, PF!t
coordinates -270 to -60).
and MSgt-PF!t promoters, in accordance with the present
20
Construction of modified promoter (PF!t-UAS-2X) with
disclosure, including the assay of Example 7.
double enhancer domain by adding the upstream actiFIG. 17 is a graphing showing average GUS activities
vating sequence (promoter coordinates -352 to -49) to
(nmole MU/min/mg protein) ofCaMV35S, PF!t, PFLt-UASthe 5' end of the core promoter domain ( -352 to +24) of
2X, FSgt-PF!t and MSgt-PF!t obtained from transformed
PClSV Fit.
Arabi dopsis protoplast individually with corresponding stan25
dard deviations.
Construction of chimeric promoter (FPF!t-UAS-lX) by
FIG. 18 are graphs showing transient GUS activities assay
intermolecular hybridization by ligating the upstream
ofCaMV35S, PF!t, PFLt-UAS-2X, FSgt-PF!t andMSgt-PF!t
activating sequence ( -270 to -60) of Figwort mosaic
promoter constructs in three different plants system namely
virus to the core promoter domain (-352 to +24) of
Petunia hybrida, Spinacea oleracia and Solanum lycopersiPClSV Fit.
cum, respectively.
30
The efficacies of the modified promoters; (PF!t-UAS-2X)
FIG. 19 are light microscope images/stains showing difand chimeric promoter (FSgt-PF!t-UAS-lX) coupled to
ferential expression of the GUS reporter gene under control of
GUS reporter gene was tested by transient (in tobacco
CaMV35S, CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t and
protoplast system) and transgenic (in tobacco plant)
MSgt-PF!t promoter constructs during different time-point of
assays.
seed germination, which are light microscopy images of 35
The
modified PF!t-UAS-2X and chimeric promoters FSgtX-gluc treated whole seedlings (21 days) of untransformed
PF!t were found to be stronger (4 to 6 fold) compared to
control and transgenic tobacco plant expressing CaMV35S,
the CaMV35S promoter widely used in plant biology.
CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t and MSgt-PF!t
promoters coupled to GUS reporter gene.
The present invention also relates to a strategy for construcFIG. 20 are micrographs for CLSM based comparative 40 tion of modified promoter; MSgt-PF!t employing promoter
analysis of the relative GUS expression under control of
sequences from Peanut Chlortic Streak Virus and Mirabilis
CaMV35S, PF!t, PF!t-UAS-2X, FSgt-PF!t and MSgt-PF!t
Mosaic Virus. This invention also describes the method of
promoter in transgenic floral organs, which are superimposed
using the said promoters in plant and protoplast system for
(bright field and fluorescent) images of ImaGene Green™
expression of any trans gene.
treated cross-sections of transgenic floral organ (style, ovary 45
Additionally features include:
and filament) expressing the GUS gene under respective proMolecular cloning of PF!t promoter fragment (PClSV
moter construct.
genomic coordinate 5725 to 6101, PC! SV-Flt promoter
FIG. 21 is a graph showing intensities of Green fluorescoordinates -352 to +24 from TSS) from Peanut Chlocence obtained from 50/60 regions of interest (ROis) of transrtic Streak Virus full-length transcript.
genic floral organs expressing above promoter construct. The 50
average intensity was determined for respective floral organs/
Molecular cloning of domain containing upstream activattissues and presented.
ing sequence, from Mirabilis Mosaic Virus sub-genomic
FIG. 22 is a graph showing average GUS activities (in
transcript (MMV-Sgt) promoter. (UAS from MMV
genomic coordinates; MMV-Sgt promoter coordinates
nmole MU/min/mg protein) from the root, leaf and stem of
transgenic tobacco seedling (21 days old) expressing GUS 55
-356 to -125).
under the control of the above promoter constructs.
Construction of recombinant promoter (MSgt-PF!t) by
FIG. 23 are graphs showing spatial distribution of GUS
intermolecular hybridization of the upstream activating
expression (in nmole MU/min/mg protein) from the root, leaf
sequence (-356 to -125) ofMirabilis Mosaic Virus to
and stem of 21 days old transgenic tobacco seedlings driven
the core promoter domain (-352 to +24) of PCISV Fit.
by CaMV35S, CaMV35S2, PF!t, PF!t-UAS-2X, FSgt-PF!t 60
The efficacies of the modified promoter (MSgt-PF!t)
and MSgt-PF!t promoter constructs under 150 f.LM Salicylic
coupled to GUS reporter gene was tested by transient (in
Acid and Abscisic acid treatment.
tobacco protoplast system) and transgenic (in tobacco
plant) assays.
DETAILED DESCRIPTION OF THE INVENTION
65

The present invention provides a strategy for construction
of modified promoters; PFit-UAS-2X and FSgt-PF!t employ-

The modified promoter, MSgt-PF!t was found to comparable/equivalent to the CaMV35S promoter, most
widely used promoter in plant biology.
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EXAMPLES

were designated as IL-2pUPPFlt-UAS-lX, IL-2pUPPFltUAS-2X and IL-2pUPFSgt-PFlt respectively.

The present invention will now be described with reference
to the following non-limiting examples and experiments.

Example 2

Example 1

Transient Assay of the Promoters in Tobacco
Protoplast System

Construction of Vector Containing Modified and
Chimeric Promoter

Protoplasts from tobacco cell suspension cultures (Xanthi
'Brad') were purified on 20% sucrose gradient after being
digested by cellulase (Sigma Cat #C0615-l G) and pectinase
(Sigma Cat #P4300-5 KU). Electroporation of protoplasts
with supercoiled DNA containing GUS reporter genes were
conducted as described earlier (Kumar eta!., 2012) by using
the GenePulser II Apparatus (BioRad) with the Capacitance
Extender II (Model165-2107). In brief, an aliquot of750-fll
containing 2x106 protoplasts in an electroporation cuvette
(0.4 em electrode gap) was electroporated (200 V used for
charging 965-f.LF capacitance for 40-50 ms) with 5-f.lg of each
following promoter constructs CaMV35S, pUPPFlt-UASIX pUPPFlt-UAS-2X and pUPFSgt-PFlt.
Transformed protoplast expressing CaMV35S, PFlt-UASlX, PFlt-UAS-2X and FSgt-PFlt were incubated in 1 mM
MUG (4-methyl-umbelliferyl-D-glucuronide) at 37° C. for
30 min. to produce MU (7-Hydroxy-4-Methylcoumarin) for
biochemical GUS estimation (Jefferson eta!., 1987) and the
result were presented in FIG. 3. pUPPFlt-UAS-2XGUS and
pUPFSgt-PFlt-UAS-lXGUS promoter showed 2.25 and 3.6
times stronger activity compared to CaMV35S promoter in
tobacco protoplast system.
To confirm the reporter gene (GUS) expression, the transformed protoplast expressing CaMV35S, PFlt-UAS-lX,
PFlt-UAS-2X and FSgt-PFlt promoter were incubated individually, in 55 mM ImaGene Green™ C12FDG!cU substrate
(ImaGene Green™ GUS Gene Expression Kit; Invitrogen,
Oregon, USA) as per kit's instructions and kept under
vacuum infiltration for 10 min initially and then incubated at
room temperature for 2-3 hrs in the dark. Fluorescence
images of protoplast the transform with CaMV35S, PFltUAS-lX, PFlt-UAS-2X and FSgt-PFlt promoter constructs
were captured using a CLSM (TCS SP5; Leica, D 68165
Mannheim, Germany). The captured fluorescence images
were presented in FIG. 4. For estimating GUS, the ImaGene
Green™ treated transformed protoplast were excited with
488 diode laser (use of 495 nm UV laser may be more appropriate) and fluorescence emissions were collected between
500 and 515 nm with detector (PMT) gain set at 1150V. GUS
localizations at cellular/tissue level were detected by green
fluorescent lipophilic fluorescein derivative (5-dodecanoylaminofluorescein).
ELISA of Protoplast Derived IL-2 Protein Driven by PFltUAS-lX PFlt-UAS-2X and FSgt-PFlt Promoter Sequence
A 100 fll PBS containing 10 flg of protein extracts from
protoplasts transformed with each ofiL-2pUPPFlt-UAS-lX,
IL-2pUPPFlt-UAS-2X and IL-2pUPFSgt-PFlt constructs
were coated into a 96 well ELISA plate. The concentration of
protoplast derived IL-2 was estimated following indirect
ELISA protocol (Vazquez et a!., 1996) using an anti-IL2
antibody (Santacruz, USA) and the result obtained is presented in FIG. 7.

10

Ia) Cloning of Modified and Chimeric Promoter
The 376 bp long PFlt-UAS-lX promoter fragment
(PClSV-FLt; SEQ ID NO: 1, FIG. 1) ( -352 to +24), 305 bp
long PFlt-UAS-2X promoter fragment (-353 to -49) and211
by long FMV-Sgt-UAS promoter fragment (-270 to -60)
were PCR amplified as described by Dey and Maiti, (1999)
using specific primer pairs containing the appropriate
sequence to generate EcoRI and Hindi sites at the 5' end and
Smai and Hindiii sites at the 3' end using corresponding
genomic DNA clone. PCR-amplified fragments were
restricted with EcoRI and Hindiii endonucleases and gel
purified. Digested promoter fragments were cloned into the
corresponding sites of pUC 119 vector; the resulting plasmids
were designated as pUCPFlt-UAS-lX, pUCPFlt-UAS-lXUAS and pUCFSgt-UAS. All of these plasmids were subjected to automated sequencing. The PFlt-UAS-lX promoter
fragment was isolated from pUCPFlt-UAS-lX clone as
Hincii-Hindiii fragment; and it was then inserted into the
Smai andHindiii sites ofpUCPFlt-UAS-lX-UAS clone and
the resulting plasmid was designated as PFlt-UAS-2X. Similarly, the PFlt-UAS-lX promoter fragment (376-bp) was isolated from pUCPFlt-UAS-lX clone as Hincii-Hindiii fragment; and it was then inserted into the Smai and Hindiii sites
of pUCFSgt-UAS clone. The resulting chimeric promoter
clone was designated as FSgt-PFlt. The plasmids were
sequenced (Sanger et a!., 1977) and the sequence of this
promoter is presented in FIG. 1, SEQ ID NO: 3.
1b) Cloning of PFlt-UAS-2X and FSgt-PFlt Promoter
Sequence in the Protoplast Expression Vector pUCPMAGUS
The PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt promoter
was isolated as EcoRI and Hindiii fragment from sequencing
vectors pUCPFlt-UAS-lX, pUCPFlt-UAS-2X and pUCFSgt-PFlt respectively and sub-cloned into the corresponding
sites of the protoplast expression vector coupled to GUS
reporter gene pUCPMAGUS (Dey andMaiti 1999) by replacing the CaMV35S promoter and the resulting clones were
designated as pUPPFlt-UAS-lX, pUPPFlt-UAS-2X and
pUPFSgt-PFlt respectively.
2a) Cloning oflnterleukin-2 (IL-2)
The 500 bp long IL-2 was PCR amplified using specific
primer sequence to incorporate Xho I and Xbai in the 5' and
3' end of the amplified gene respectively. It was then cloned
into the corresponding sites of pUC119 containing PFltUAS-lX, PFlt-UAS-2X and FSgt-PFlt promoters and the
resulting plasmid was named as IL-2pUCPFlt-UAS-lX,
IL-2pUCPFlt-UAS-2 and IL-2pUCF Sgt-PFlt respectively.
2b) Cloning of IL-2PFlt-UAS-lX, IL-2PFlt-UAS-2X and
IL-2FSgt-PFlt in the Protoplast Expression Vector p
UCPMAGUS
The IL-2 gene was isolated as Xhoi and Xbai fragment
from sequencing vectors IL-2pUCPFlt-UAS-lX, IL-2pUCPFlt-UAS-2X and IL-2pUCFSgt-PFlt respectively and subcloned into the corresponding sites of the protoplast expressian vector pUCPMAGUS (Dey and Maiti 1999) by
replacing the CaMV35S promoter and the resulting clones
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Construction of Plant Expression Vectors with
PFlt-UAS-lX, PFlt-UAS-2X and FSgt-PFlt
Promoters, Plant Transformation and Analysis of
Transgenic Plants
65

Promoter fragment PFlt-UAS-lX (376 bp) (SEQ ID NO:
1), PFlt-UAS-2X (686 bp) (SEQ ID NO: 2) and FSgt-PFlt
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(593 bp) (SEQ ID NO: 3) (See FIG. 1) were purified from
corresponding pUC-clones and were cloned into the plant
expression vector pKYLX71GUS (Schardl eta!., 1987; Dey
and Maiti 1999) at its unique EcoRI and Hindiii sites that
flank the promoter by replacing the CaMV35S promoter.
Resulting plant expression vectors were designated pKPFltUAS-1X, pKPFlt-UAS-2X and pKFSgt-PFlt respectively.
Promoter constructs namely pKYLX-GUS (containing
CaMV35S promoter), pKPFlt-UAS-1X-GUS, pKPFlt-UAS2X-GUS and pKFSgt-PFlt-GUS were introduced into Agrobacterium tumefaciens strain C58C1 :Pgv3850 by freeze thaw
method. Tobacco plants (Nicotiana tabacum cv Samsun NN)
were transformed with the engineered Agrobacterium as
described earlier (Maiti eta!., 1993). About 10 (ten) independent plant lines were generated for each construct. Regenerated Kanamycin-resistant plants were grown under greenhouse conditions (Temp-28±2° C., humidity-60 to 70%)
until setting of seed. Seeds were collected from mature plant
and germinated on Kanamycin antibiotic 300 mg per liter.
Analysis of GUS Expression in Transgenic Tobacco Plants
Independent tobacco transgenic lines were developed
using CaMV35S, PFlt-UAS-1X, PFlt-UAS-2X and FSgtPFlt promoter as described earlier. Comparative GUS expression analyses were conducted using plant leaves (second from
the top) extract following protocol of Jefferson et a!., 1987.
The result obtained was presented in FIG. 5. Transgenic
plants expressing the PFlt-UAS-2X and FSgt-PFlt promoter
showed 1.2 and 2 times stronger activity compared to the
CaMV 35S promoter.
Transgenic plant sections expressing the GUS gene developed for each constructs were immersed into histochemical

GUS staining buffer (1 00 mM NaP04 , 0.5 mM K3 [Fe(CN) 6 ,
0.5 mM K4 [Fe(CN) 6 ], 10 mM EDTA, 1 mg/ml 5-bromo-4chloro-3-indolyl-b-D-glucuronide (X-glue), vacuum infiltrated under pressure for 10 min followed by incubation at 3 7°
C. for overnight. Samples were then washed and fixed (in
50% ethanol, 7% acetic acid). The intensity of color development in different tissues was monitored and photographs
were taken by using inverted Leica DM LS2 microscope at 4x
magnification (FIG. 8).
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Reactions of qRT-PCR were performed as described earlier
by Kumar et a!., 2011. The eDNA was synthesized using
RNA (DNasei treated) isolated from transgenic tobacco
plants expressing CaMV35S, PFlt-UAS-1X, PFlt-UAS-2X
and FSgt-PFlt promoter constructs individually using eDNA
synthesis Kit (Fermentas, USA). The qRT-PCR for relative
expression analysis was performed using the corresponding
eDNA template (1: 15 dilution) and SYBR Premix Ex Takirm
II (Perfect Real Time, Takara Bio Inc., Japan) employing
Opticon-2 Real-time PCR machine (MJ Research, Bio-Rad;
Model; CFD-3220). Gene specific primers for GUS were
used at a concentration of 0.8 mmolar to get 95% efficiency.
The absence of genomic DNA contamination was confirmed
using minus-reverse-transcriptase controls. The Ct value for
each reaction was obtained with the help of the software
attached with the machine and fold changes in the transcript
levels of each construct (considered for qRT-PCR) were presented (FIG. 6).

TABLE 1
Primer Sequences

SEQ.

Name of
Constructs

Primer Sequence to amplify
respective promoter in 5' to 3' direction

6.

PF1t-UAS-1X
(forward)

GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA

7.

PF1t-UAS-1X
(reverse)

ATGCAGAAGCTTATGGCCGTGTCTTCTCGA

8.

PF1t-UAS-2X
(forward)

GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA

9.

PF1t-UAS-2X
(reverse)

ATGCAGAAGCTTATGGCCGTGTCTTCTCGA

10.

FSgt-PFlt
(forward)

CCCGAATTCGTCGACTTTACAGTAAGAACTGATAACA

11.

FSgt-PFlt
(reverse)

ATGCAGAAGCTTATGGCCGTGTCTTCTCGA

12.

GUS (real time)
(forward)

GATCGCGAAAACTGTGGAAT

13.

GUS (real time)
(reverse)

TAATGAGTGACCGCATCGAA

14.

Interleukin 2
(forward)

GCGGGCTCGAGAACCATGGGTTACAGCATGCAGCTCGCA

15.

Interleukin 2
(reverse)

ATGCAGTCTAGATCAGTGATGGTGATGGTGATGTTGAGGGCTTGTTGAGAT

NO.
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Information for SEQ ID No: 1 (FIG. 1)
(i) Sequence characteristics: DNA (Genomic)
(ii) Molecule type: Recombinant DNA
(iii) Original source:
(A) Organism: Peanut Chlortic Streak Virus (PClSV)
**This promoter DNA clone PFlt-UAS-lX is submitted to
Microbial Type Culture Collection and Gene Bank (MTCC),
Chandigarh, India under Budapest treaty.
Information for SEQ ID No: 2 (FIG. 1)
(iv) Sequence characteristics: DNA (Genomic)
(v) Molecule type: Recombinant DNA
(vi) Original source:
(A) Organism: Peanut Chlortic Streak Virus (PC! SV)
**This promoter DNA clone PFlt-UAS-2X is being submitted to Microbial Type Culture Collection and Gene Bank
(MTCC), Chandigarh, India under the Budapest treaty. All
restrictions to the deposit will be revoked upon allowance of
a patent covering the subject matter and the deposit will be
replenished be if needed.
Information for SEQ ID No: 3 (FIG. 1)
(vii) Sequence characteristics: DNA (Genomic)
(viii) Molecule type: Recombinant DNA
(ix) Original source:
(A) Organism: Peanut Chlortic Streak Virus (PClSV) and
Figwort mosaic caulimovirus (FMV).
**This promoter DNA clone FSgt-PFlt is being submitted to
Microbial Type Culture Collection and Gene Bank (MTCC),
Chandigarh, India under the Budapest treaty. All restrictions
to the deposit will be revoked upon allowance of a patent
covering the subject matter and the deposit will be replenished be if needed.

2a) Cloning ofiL-2 in the Protoplast Expression Vector Carrying PFlt and MSgt-PFlt Promoter Fragments.
The 500 bp long IL-2 gene was PCR amplified using specific primer sequence (Table 2) to incorporate Xho I andXbai
in the 5' and 3' end of the amplified gene respectively. The
IL-2 gene was cloned into the corresponding sites of the
protoplast expression vector (Dey and Maiti 1999) by replacing the CaMV35S promoter and the resulting clones were
designated as pUPPFlt-IL-2 and pUPMSgt-PFlt-IL-2 respectively.
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Example 5
Construction of Vector Containing Modified and
Chimeric Promoter
Ia) Cloning of Modified and Chimeric Promoter
The 3 7 6 bp long PFlt promoter fragment (-3 52 to +24) and
232 bp long MMV-Sgt promoter fragment(~ 356 to -125)
containing UAS domain were PCR amplified as described by
Dey and Maiti, (1999) using specific primer pairs containing
the appropriate sequence to generate EcoRI and Hindi sites
at the 5' end and Smai and Hindiii sites at the 3' end using
corresponding genomic DNA clone. PCR-amplified fragments were restricted with EcoRI and Hindiii endonucleases
and gel purified. Digested promoter fragments were cloned
into the corresponding sites of pUC119 vector; the resulting
plasmids were designated asp UCPFlt promoter fragment and
pUCMSgt-UAS. All of these plasmids were subjected to
automated sequencing. The 376 bp long PFlt promoter fragment was isolated from pUCPFlt clone as Hincii-Hindiii
fragment; and it was then inserted into the Smai and Hindiii
sites of pUCMSgt-UAS clone. The resulting chimeric promoter clone was designated as MSgt-PFlt. The plasmids were
sequenced (Sanger et a!., 1977) and the sequence of this
promoter is presented in FIG. 9.
1b) Cloning of MSgt-PFlt Promoter Sequence in the Protoplast Expression Vector pUCPMAGUS
The PFlt promoter fragment and MSgt-PFlt promoter were
isolated as EcoRI and Hindiii fragments from corresponding
pUC based clones as discussed above and sub-cloned into the
corresponding sites of the protoplast expression vector
coupled to GUS reporter gene pUCPMAGUS (Dey and Maiti
1999) by replacing the CaMV35S promoter and the resulting
clones were designated as pUPPFlt and pUPMSgt-PFlt
respectively.
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Transient Assay of the Promoters in Tobacco
Protoplast System
Protoplasts from tobacco cell suspension cultures (Xanthi
'Brad') were purified on 20% sucrose gradient after being
digested by cellulase (Sigma Cat #C0615-l G) and pectinase
(Sigma Cat II P4300-5 KU). Electroporation of protoplasts
with supercoiled DNA containing GUS reporter genes were
conducted as described earlier (Kumar eta!., 2012) by using
the GenePulser II Apparatus (BioRad) with the Capacitance
Extenderii (Model165-2107). In brief, an aliquot of750-0
containing 2x106 protoplasts in an electroporation cuvette
(0.4 em electrode gap) was electroporated (200 V used for
charging 965-f.LF capacitance for 40-50 ms) with 5-f.lg of each
following promoter constructs CaMV35S, pUPPFlt and
pUPMSgt-PFlt.
Transformed protoplast expressing CaMV35S, PFlt and
MSgt-PFlt were incubated in 1 mM MUG (4-methyl-umbellifeiyl-D-glucuronide) at 37° C. for 30 min. to produce MU
(7-Hydroxy-4-Methylcoumarin) for biochemical GUS estimation (Jefferson eta!., 1987) and the result were presented in
FIG. 11. We observed that pUPMSgt-PFlt promoter showed
equivalent activity compared to that obtained from
CaMV35S promoter in tobacco protoplast system.
To further confirm the reporter gene (GUS) expression, in
protoplast, we incubated the transformed protoplast expressing CaMV35S, PFlt and MSgt-PFlt promoter individually, in
55 mM ImaGene Green™ C12FDGlcU substrate (ImaGene
Green™ GUS Gene Expression Kit; Invitrogen, Oregon,
USA) as per kit's instructions and kept under vacuum infiltration for 10 min initially and then incubated at room temperature for 2-3 hrs in the dark. Fluorescence images of
protoplast, transform with CaMV35S, PFlt promoter fragment and MSgt-PFlt promoter constructs were captured using
a CLSM (TCS SP5; Leica, D 68165 Mannheim, Germany).
The captured fluorescence images were presented in FIG. 12.
For estimating GUS, the ImaGene Green™ treated transformed protoplast were excited with 488 diode laser (use of
495 urn UV laser may be more appropriate) and fluorescence
emissions were collected between 500 and 515 urn with
detector (PMT) gain set at 1150V. GUS localizations at cellular/tissue level were detected by green fluorescent lipophilic fluorescein derivative (5-dodecanoylaminofluorescein).
ELISA of Protoplast Derived IL-2 Protein Driven by PFit
Promoter Fragment and MSgt-PFlt Promoter Constructs
A 100 fll PBS containing 10 flg of protein extracts from
protoplasts transformed with each of PFlt-IL-2 promoter
fragment and MSgt-PFlt-IL-2 constructs were coated into a
96 well ELISA plate. The concentration of protoplast derived
IL-2 was estimated following indirect ELISA protocol

US 9,322,028 Bl
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(Vazquez eta!., 1996) using an anti-IL-2 antibody (Santacruz,
USA) and the result obtained is presented in FIG. 15.

5-bromo-4-chloro-3-indolyl-b-D-glucuronide
(X -glue),
vacuum infiltrated under pressure for 10 mM followed by
incubation at 37° C. overnight. Samples were then washed
and fixed (in 50% ethanol, 7% acetic acid). The intensity of
color development in different tissues was monitored and
photographs were taken by using inverted Leica DM LS2
microscope at 4x magnification (FIG. 16).

Example 7
Construction of Plant Expression Vectors with PFlt
and MSgt-PFlt Promoters, Plant Transformation and
Analysis of Transgenic Plants
Promoter fragments PFlt (376 bp) and MSgt-PFlt (614 bp)
were purified from corresponding pUC-clones and were subcloned into the plant expression vector pKYLX71GUS
(Schardl eta!., 1987; Dey andMaiti 1999) at its uniqueEcoR1
and Hindiii sites that flank the promoter by replacing the
CaMV35S promoter. Resulting plant expression vectors were
designated pKPFlt-GUS and pK1 VISgt-PFlt-GUS respectively.
Promoter constructs namely pKYLX-GUS (containing
CaMV35S promoter), pKPFlt-GUS and pK1 VISgt-PFltGUS were introduced into Agrobacterium tumefaciens strain
C58C1 :Pgv3850 by freeze thaw method. Tobacco plants
(Nicotiana tabacum cv Samsun NN) were transformed with
the engineered Agrobacterium as described earlier (Maiti et
a!., 1993). About 10 (ten) independent plant lines were generated for each construct. Regenerated Kanamycin-resistant
plants were grown under greenhouse conditions (Temp28±20 C., humidity-60 to 70%) until setting of seed. Seeds
were collected from mature plant and germinated on Kanamycin antibiotic 300 mg per liter.

Example 8
10

15

20

25

Reactions of qRT-PCR were performed as described earlier
by Kumar et a!., 2011. The eDNA was synthesized using
RNA (DNasei treated) isolated from transgenic tobacco
plants expressing CaMV35S, PFlt and MSgt-PFlt promoter
constructs individually using eDNA synthesis Kit (Fermentas, USA). The qRT-PCR for relative expression analysis was
performed using the corresponding eDNA template (1:15
dilution) and SYBR Premix Ex Taql'm II (Perfect Real Time,
Takara Bio Inc., Japan) employing Opticon-2 Real-time PCR
machine (MJ Research, Bio.-Rad; Model; CFD-3220). Gene
specific primers for GUS were used at a concentration of0.8
mmolar to get 95% efficiency. The absence of genomic DNA
contamination was confirmed using minus-reverse-transcriptase controls. The Ct value for each reaction was
obtained with the help of the software attached with the
machine and fold changes in the transcript levels of each
construct (considered for qRT-PCR) were presented (FIG.
14).
TABLE 2
Primer Se uences

Sequence Name of
No.
Constructs

Primer Sequence to amplify
respective promoter in 5' to 3' direction

16.

PF1t (forward)

GCGGGCGAATTCGTCAACGAGTTTTTACTTCGGACA

17.

PF1t (reverse)

ATGCAGAAGCTTATGGCCGTGTCTTCTCGA

18.

MSgt-PFlt
(forward)

ACTGAATTCGTCGACAGCGGTAAAACAGGTGATTACT

19.

MSgt-PFlt
(reverse)

ATGCAGAAGCTTATGGCCGTGTCTTCTCGA

12.

GUS (real time)
(forward)

GATCGCGAAAACTGTGGAAT

13.

GUS (real time)
(reverse)

TAATGAGTGACCGCATCGAA

14.

Interleukin 2

GCGGGCTCGAGAACCATGGGTTACAGCATGCAGCTCGCA

(forward)
15.

ATGCAGTCTAGATCAGTGATGGTGATGGTGATGTTGAGGGCTTGTTGAGAT

Interleukin 2

(reverse)

Analysis of GUS Expression in Transgenic Tobacco Plants
Independent tobacco transgenic lines were developed
using CaMV35S, PFlt and MSgt-PFlt promoters as described
earlier. Comparative GUS expression analyses were conducted using plant leaf (second from the top) extracts following protocol of Jefferson eta!., 1987. The result obtained was
presented in FIG. 13. Transgenic plants expressing the MSgtPFlt promoter showed equivalent activity compared to the
CaMV 35S promoter.
Transgenic plant sections expressing the GUS gene developed under each constructs were immersed into histochemical GUS staining buffer [100 mM NaP04 , 0.5 mM K3 [Fe
(CN) 6 , 0.5 mM K4 [Fe(CN) 6 ], 10 mM EDTA, 1 mg/ml
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Information for SEQ ID No: 4 (FIG. 9)
(i) Sequence characteristics: DNA (Genomic)
(ii) Molecule type: Recombinant DNA
(iii) Original source:
(A) Organism: Peanut Chlortic Streak Virus (PC1SV) and
Mirabilis Mosaic Virus (MMV).
**This promoter DNA clone MSgt-PFlt is being submitted to
Microbial Type Culture Collection and Gene Bank (MTCC),
Chandigarh, India under the Budapest treaty. All restrictions
to the deposit will be revoked upon allowance of a patent
covering the subject matter and the deposit will be replenished be if needed.
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Example 9

old) expressing pKYLXGUS, pKPFltGUS, pKPFlt-UAS2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS constructs were immersed separately into histochemical GUS
staining buffer [100 mM NaP04 , 0.5 mM K 3 [Fe(CN) 6 , 0.5
mM K4 [Fe(CN) 6 ], 10 mM EDTA, 1 mg/ml 5-bromo-4chloro-3-indolyl-b-D-glucuronide (X-gluc)], vacuum infiltrated for 10 min followed by incubation at 37° C. for overnight. Treated samples were subsequently washed and kept in
fixing solutions (50% ethanol, 7% acetic acid). The intensities of blue color development in different tissues were
recorded using Leica DM LS2 microscope (Inverted) at lOx
magnification. (FIG. 19).
Detailed histochemical expression analysis of the reporter
gene (GUS) in different sections of floral organs/parts of
transgenic plant expressing pKYLXGUS, pKPFltGUS, pKPFlt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS
constructs was carried out individually in presence of 55 mM
ImaGene Green™ C12FDGlcU substrate (ImaGene
Green™ GUS Gene Expression Kit; Invitrogen, Oregon,
USA) as per Kit's instructions. Subsequently, treated samples
were kept in dark after vacuum infiltration for 10 minutes.
Fluorescence images of the ImaGene Green™ treated floral
sections were captured using a CLSM (TCSSP5; Leica,
D-68165 Mannheim, Germany) and GUS localizations at
cellular/tissue level were detected. (FIG. 20) Intensities of
green fluorescence obtained from different 50/60 ROis (regions of interest) of transgenic floral organs for individual
promoter construct were recorded using 'LAS-AF' analytical
software and average intensity obtained from different floral
organ/tissue were measured (FIG. 21).

Transient Assay of Recombinant Promoter in
Arabidopsis Protoplast
5

Sterile young leaves of Arabidopsis plants were chopped
under sterile condition and placed in MS agar media containing the following supplements: 1 mg/L ofNaphthalene acetic
acid (NAA), indole-3-acetic acid (IAA), 2,4-Dichlorophenoxyacetic acid (2,4-D) and 0.5 mg/L of 6-Benzylaminopurine (BAP). The plates were kept in dark at temperature 24 o C.
for one month for callus development. Arabidopsis callus
were shred from plates to 30 ml enzyme solution containing
2% cellulose and 2% pectinase and incubated in dark at 50
rpm for 4 hours. After 4 hours, digested Arabidopsis cells
were passed through a sieve, the flow through was collected
and centrifuged at 200 g for 5 minutes. The pellet was suspended in 1 ml 0.6 M mannitol and 0.2% CaC1 2 . Finally, the
protoplasts were purified over 20% sucrose cushion and
resuspended in a fresh medium containing 0.6 M mannitol
and 0.2% CaC1 2 . The isolated protoplast was counted with the
help ofhaemocytometer.
An aliquot of 105 Arabi dopsis protoplasts were electroporated with 10 flg plasmid DNA extracted individually from
pUCPMA (vector control), pUCPMAGUS, PFltGUS, PFltUAS-2XGUS, FSgt-PFltGUS and MSgt-PFltGUS constructs
following protocol described earlier and fluorimetric GUS
assay was carried out following standard protocols (Bradford
1976; Jefferson eta!. 1987). FIG. 17 presented the mean GUS
activity obtained from four independent experiments for each
of the above promoter constructs.

10

15

20

25

30

Example 12
Example 10
Transient Agro-Infiltration Assay of Chimeric
Promoters in Solanum lycopersicum, Petunia
Hybrida and Spinacia oleracea
Agrobacterium tumefaciens strain C58Cl :pGV3850 was
transformed with pKPFltGUS, pKPFlt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS constructs (pKYLXGUS based) individually following the freeze thaw method as
described earlier (Chen et a!. 1994). Agro bacteria lines were
grown as individual culture as described earlier. Leaves of
Spinacea oleracea, Petunia hybrida and Solanum lycopersicum (var. Samsun NN) were mechanically infused with each
Agrobacterium constructs individually as described (Imogen
et a!. 2006). Quantitative measurements of the GUS activity
were performed 3-4 days post infusion following standard
protocol. FIG. 18 presented the mean GUS activity (obtained
from four independent experiments) for each of the promoter
constructs in above mentioned plant with respective standard
deviations.
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Spatial Distribution of GUS Activities Obtained
from CaMV35S, CaMV35S2, PFlt, PFlt-UAS-2X,
FSgt-PFlt and MSgt-PFlt Promoters
On an average, 8-11 independent plant lines were generated for each construct and maintained under standard greenhouse conditions till setting of seeds. Seeds were collected
from each plant line under each construct and germinated on
MS plate supplemented with 300 mg Kanlliter; segregation
analysis for each line was determined (with KanR: Kans=3: 1).
Kanamycin-resistant seedlings (T 1 generation) under each
construct with appropriate segregation ratio were used for
further analysis. Leaf, root and stem protein of transgenic
seedling (21 days old) expressing above promoter constructs
individually were extracted and the average GUS activity was
measured according to the standard protocols (Bradford,
1976; Jefferson et a!., 1987). FIG. 22 presented the mean
promoter activity for each of the promoter construct with
respective standard deviation.
Example 13

Example 11

55

SA and ABA Treatment
Histochemical Staining of Germinating Seeds,
Whole Seedlings and Fluorescent Imaging of Floral
Organs
60

Longitudinal cross-sections of germinating seeds expressing pKYLXGUS, pKPFltGUS, pKPFlt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS promoter constructs
individually were performed at different time-points Viz. 0,
2nd, 4'h and 8'h day of post germination using a Cryostat
(Modell CM1850-l-1, Leica ). Longitudinal sections of transgenic seed and whole seedlings of transgenic plant (21 days

65

Transgenic tobacco seeds expressing pKYLX (Control),
pKYLX, pKYLXGUS, pKYLXGUS35S 2 , pKPFltGUS,
pKPFlt-UAS-2XGUS, pKFSgt-PFltGUS and pKMSgt-PFltGUS constructs were germinated on half MS plate (containing 300 mg/liter Kanamycin) and allowed to grow under
tissue culture conditions as described earlier (Kumar et a!.
2012). The whole transgenic seedlings (21 days old) under
each constructs were treated individually in the presence of
150 f.LM SA (pH 6.8) and ABA (pH 6.8) for a period of0-24 h,
respectively.
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After treatments, GUS activity from SA- andABA-treated
root, leaf, stem portion of seedlings under each of the above
mentioned promoter constructs were measured (Bradford
1976; Jefferson eta!. 1987). The data obtained as a mean of
four independent experiments in FIG. 9 with respective standard deviation presented in FIG. 23.
The following are the accession numbers of your cultures
deposited in Microbial Type Culture Collection and Gene
Bank Institute of Microbial Technology (MTCC), Sector
39-A, Chandigarh-160036, INDIA, under Budapest treaty.
E. coli (TGl)-pUC PF!t-UAS-2X=MTCC 5825
E. coli (TGl)-pUC FSgt-PF!t=MTCC 5826
E. coli (TGl)-pUC MSgt-PF!t=MTCC 5827
It will now be clear that the present invention provides
features and advantages not found in prior known promoters.
Further, one of ordinary skill in the art will recognize that
aspects of the present disclosure can be modified using routine techniques consistent with the present disclosure.

8. Goodrich J A, Tjian R (2010) Modes of transcriptional
regulation: Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene
regulation. Nat Rev Genetics 11: 549-558.
5 9. Imogen A S, John R, Anne K, Chris H (2006) Rapid,
transient expression of fluorescent fusion proteins in
tobacco plants and generation of stably transformed plants.
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SEQUENCE LISTING

<160> NUMBER OF SEQ ID NOS, 19
<210> SEQ ID NO 1
<211> LENGTH, 376
<212> TYPE, DNA
<213> ORGANISM, Artificial Sequence
<220> FEATURE,
<223> OTHER INFORMATION, combined sequence from PFlt and UAS
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20
-continued

<400> SEQUENCE,

1

agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta aaacaagaaa

60

tatgcttacg tctacagagg gatttctctg aagatcatgt ttgccagcta tgcgaacaat

120

catcgggaga tcttgagcca atcaaagagg agtgatgtag acctaaagca ataatggagc

180

catgacgtaa gggcttacgc ccatacgaaa taattaaagg ctgatgtgac ctgtcggtct

240

ctcagaacct ttacttttta tatttggcgt gtatttttaa atttccacgg caatgacgat

300

gtgacctgtg catccgcttt gcctataaat aagttttagt ttgtattgat cgacacgatc

360

gagaagacac ggccat

376

<210> SEQ ID NO 2
<211> LENGTH, 686
<212> TYPE, DNA
<213> ORGANISM, Artificial Sequence
<220> FEATURE,
<223> OTHER INFORMATION, combined promotor from PFlt and UAS
<400> SEQUENCE,

2

agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta aaacaagaaa

60

tatgcttacg tctacagagg gatttctctg aagatcatgt tgccagctat gcgaacaatc

120

atcgggagat cttgagccaa tcaaagagga gtgatgtaga cctaaagcaa taatggagcc

180

atgacgtaag ggcttacgcc catacgaaat aattaaaggc tgatgtgacc tgtcggtctc

240

tcagaacctt tactttttat atttggcgtg tatttttaaa tttccacggc aatgacgagg

300

tgacccaacg agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta

360

aaacaagaaa tatgcttacg tctacagagg gatttctctg aagatcatgt ttgccagcaa

420

tgcgaacaat catcgggaga tcctgagcca atcaaagagg agtgatgtag acctaaagca

480

ataatggagc catgacgtaa gggcttacgc ccatacgaaa taattaaagg ctgatgtgac

540

ctgtcggtct ctcagaacct ttacttttta tatttggcgt gtatttttaa atttccacgg

600

caatgacgat gtggcctgtg catccgcttt gcctataaat aagttttagt ttgtattgat

660

cgacacgatc gagaagacac ggccat

686

<210> SEQ ID NO 3
<211> LENGTH, 593
<212> TYPE, DNA
<213> ORGANISM, Artificial Sequence
<220> FEATURE,
<223> OTHER INFORMATION, combined promoter clone FSgt and PFl
<400> SEQUENCE,

3

ttacagtaag aactgataac aaaaatttta cttatttcct tagaattaat cttaaaggtg

60

atagtaaaca aggacgatta gtccgttggc aaaattggtt cagcaggtat caatttgatg

120

tcgaacatct tgaaggtgta aaaaacgttt tagcagattg cctcacgaga gattttaatg

180

cttaaaaacg taagcgctga cgtatgattt cccaacgagt ttttacttcg gacagtcaaa

240

aatgagttta acttctcagc cgaggtaaaa caagaaatat gcttacgtct acagagggat

300

ttctctgaag atcatgtttg ccagcaatgc gaacaatcat cgggagatcc tgagccaatc

360

aaagaggagt gatgtagacc taaagcaata atggagccat gacgtaaggg cttacgccca

420

tacgaaataa ttaaaggctg atgtgacctg tcggtctctc agaaccttta ctttttatat

480

ttggcgtgta tttttaaatt tccacggcaa tgacgatgtg gcctgtgcat ccgctttgcc

540

tataaataag ttttagtttg tattgatcga cacgatcgag aagacacggc cat

593
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22
-continued

<210> SEQ ID NO 4
<211> LENGTH, 614
<212> TYPE, DNA
<213> ORGANISM, Artificial Sequence
<220> FEATURE,
<223> OTHER INFORMATION, combined promoter clone from MSgt and PFlt
<400> SEQUENCE,

4

cggtaaaaca ggtgattact aaatttagta tttatctaac ccctgtttgt tttacagtca

60

ggacagataa tgtaaatctt ttaaaaggat ttatgaataa aaagattact ggtgacagta

120

aacagggaag gctaataaga tggcaaatgt ggttttcaca ttacaccttt aaggtggacc

180

acctaaaagg agaacaaaat gtgctggctg attatctcac cagagaattc ccccaacgag

240

tttttacttc ggacagtcaa aaatgagttt aacttctcag ccgaggtaaa acaagaaata

300

tgcttacgtc tacagaggga tttctctgaa gatcatgttt gccagcaatg cgaacaatca

360

tcgggagatc ctgagccaat caaagaggag tgatgtagac ctaaagcaat aatggagcca

420

tgacgtaagg gcttacgccc atacgaaata attaaaggct gatgtgacct gtcggtctct

480

cagaaccttt actttttata tttggcgtgt atttttaaat ttccacggca atgacgatgt

540

ggcctgtgca tccgctttgc ctataaataa gttttagttt gtattgatcg acacgatcga

600

gaagacacgg ccat

614

<210> SEQ ID NO 5
<211> LENGTH, 376
<212> TYPE, DNA
<213> ORGANISM, Peanut chlorotic streak virus
<400> SEQUENCE,

5

agtttttact tcggacagtc aaaaatgagt ttaacttctc agccgaggta aaacaagaaa

60

tatgcttacg tctacagagg gatttctctg aagatcatgt ttgccagcta tgcgaacaat

120

catcgggaga tcttgagcca atcaaagagg agtgatgtag acctaaagca ataatggagc

180

catgacgtaa gggcttacgc ccatacgaaa taattaaagg ctgatgtgac ctgtcggtct

240

ctcagaacct ttacttttta tatttggcgt gtatttttaa atttccacgg caatgacgat

300

gtgacctgtg catccgcttt gcctataaat aagttttagt ttgtattgat cgacacgatc

360

gagaagacac ggccat

376

<210>
<211>
<212>
<213>
<220>
<223>

SEQ ID NO 6
LENGTH, 36
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, promotor sequence

<400> SEQUENCE,
gcgggcgaat tcgtcaacga gtttttactt cggaca

<210>
<211>
<212>
<213>
<220>
<223>

36

SEQ ID NO 7
LENGTH, 30
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer sequence

<400> SEQUENCE, 7
atgcagaagc ttatggccgt gtcttctcga

30
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<210>
<211>
<212>
<213>
<220>
<223>

SEQ ID NO 8
LENGTH, 36
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer seqeunece

<400> SEQUENCE, 8
gcgggcgaat tcgtcaacga gtttttactt cggaca

<210>
<211>
<212>
<213>
<220>
<223>

36

SEQ ID NO 9
LENGTH, 30
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer sequence

<400> SEQUENCE, 9
atgcagaagc ttatggccgt gtcttctcga

<210>
<211>
<212>
<213>
<220>
<223>

30

SEQ ID NO 10
LENGTH, 37
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 10
cccgaattcg tcgactttac agtaagaact gataaca

<210>
<211>
<212>
<213>
<220>
<223>

37

SEQ ID NO 11
LENGTH, 30
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 11
atgcagaagc ttatggccgt gtcttctcga

<210>
<211>
<212>
<213>
<220>
<223>

30

SEQ ID NO 12
LENGTH, 20
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 12
gatcgcgaaa actgtggaat

<210>
<211>
<212>
<213>
<220>
<223>

20

SEQ ID NO 13
LENGTH, 20
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 13
taatgagtga ccgcatcgaa

<210>
<211>
<212>
<213>
<220>
<223>

SEQ ID NO 14
LENGTH, 39
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

20
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<400> SEQUENCE, 14
gcgggctcga gaaccatggg ttacagcatg cagctcgca

<210>
<211>
<212>
<213>
<220>
<223>

39

SEQ ID NO 15
LENGTH, 51
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 15
atgcagtcta gatcagtgat ggtgatggtg atgttgaggg cttgttgaga t

<210>
<211>
<212>
<213>
<220>
<223>

51

SEQ ID NO 16
LENGTH, 36
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 16
gcgggcgaat tcgtcaacga gtttttactt cggaca

<210>
<211>
<212>
<213>
<220>
<223>

36

SEQ ID NO 17
LENGTH, 30
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 17
atgcagaagc ttatggccgt gtcttctcga

<210>
<211>
<212>
<213>
<220>
<223>

30

SEQ ID NO 18
LENGTH, 37
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 18
37

actgaattcg tcgacagcgg taaaacaggt gattact

<210>
<211>
<212>
<213>
<220>
<223>

SEQ ID NO 19
LENGTH, 30
TYPE, DNA
ORGANISM, Artificial Sequence
FEATURE,
OTHER INFORMATION, primer

<400> SEQUENCE, 19
atgcagaagc ttatggccgt gtcttctcga

30

55

The invention claimed is:
1. An isolated non-naturally occurring DNA molecule,

comprising a Peanut Chlortic Streak Virus (PClSV) fulllength transcript promoter (Fit) fragment, and a Mirabilis
Mosaic Virus (MMV) subgenomic transcript promoter (Sgt)
fragment, comprising the sequence of SEQ ID NO: 4.
2. The isolated DNA molecule of claim 1, wherein

the PC! SV full-length transcript promoter fragment comprises a fragment between coordinates -353 to +24, and

60

the MMV Sgt promoter fragment comprises a fragment
between coordinates -356 to -125.
3. The isolated DNA molecule of claim 2, wherein the
MMV Sgt fragment is ligated to the 5' end of the PClSV Fit
fragment.
4. The isolated DNA molecule of claim 1, having activity
that is at least 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95,
96, 97, 98, or 99% as compared to the activity of a CaMV35S
promoter.

* * * * *

